CDMO Market Insight, Pricing and Benchmarking Reports

NICE INSIGHT REPORT

Gene Therapy:Market Insight, CDMO Pricing and Competitor Benchmarking

Coming January 2025

2025 gene therapy CDMO pricing data and benchmarking report
Over 50 capability profiles of CDMOs specializing in gene therapy
Exclusive insights into gene therapy manufacturing market intelligence
Scientific analysis of gene therapy development and applications
Essential market reviews for CDMOs, innovators and investors.

Contact Sales

Key market intelligence for innovators, CDMOs and investors in the gene therapy market.

Exclusive CDMO pricing data for benchmarking

Measure your business against your peers using our robust analysis of the gene therapy contract development and manufacturing market. Our pricing matrix comprises material cost, infrastructure and development process data from CDMOs all over the world so you can make informed decisions to best position your business.

Scientific analysis of gene therapies

Comprehensive overview of the gene therapy landscape in 2024, including information on AAV, Lentiviral and non-viral gene therapies. Discover the trends and technologies shaping gene therapy development and manufacturing with exclusive input from innovators, CDMO owners, PhDs and researchers across advanced therapeutics.

Essential price benchmarking, scientific analysis and market intelligence for gene therapy manufacturing — all in one report.

Contact Sales

The Gene Therapy: Market Insight, CDMO Pricing and Competitor Benchmarking provides

/hubfs/2024%20Reports/10_Gene/01%20pricing%20data%20icon%2065x65@2x.png

Competitive benchmarking data from gene therapy CDMOs all over the world

/hubfs/2024%20Reports/10_Gene/02%20profiles%20icon%2065x65@2x.png

50+ company profiles of companies specializing in gene therapies

/hubfs/2024%20Reports/10_Gene/03%20scientific%20analysis%20icon%2065x65@2x.png

Scientific analysis of the gene therapy development and manufacturing process

/hubfs/2024%20Reports/10_Gene/04%20benefits%20icon%2065x65@2x.png

Unique benefits and complexities of gene therapies in regards to accessibility, cost and applications

/hubfs/2024%20Reports/10_Gene/05%20investment%20outlook%20icon%2065x65@2x.png

Investment outlook of the gene therapy market — analyzing economic and regulatory conditions

/hubfs/2024%20Reports/10_Gene/06%20innovations%20icon%2065x65@2x.png

Innovations and breakthroughs that are powering gene therapy development and manufacturing

Over 800 hours of data collection and analysis

from interviews, primary research and progressive study.